Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease

被引:23
作者
Zhao, Luqing [1 ]
Zhang, Shengsheng [1 ]
He, Peijian [2 ]
机构
[1] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Digest Dis Ctr, 23 Meishuguanhou St, Beijing 100010, Peoples R China
[2] Emory Univ, Dept Med, Div Digest Dis, Whitehead Res Bldg Room 201,615 Michael St, Atlanta, GA 30322 USA
关键词
Inflammatory bowel disease; herbal medicines; epithelial barrier; microbiota; immune response; pathogenesis; SODIUM-INDUCED COLITIS; REGULATORY T-CELLS; INTESTINAL EPITHELIAL-CELLS; PREGNANE X RECEPTOR; NF-KAPPA-B; BARRIER FUNCTION; GUT MICROBIOTA; ANTIINFLAMMATORY ACTIVITY; ULCERATIVE-COLITIS; DENDRITIC CELLS;
D O I
10.2174/1381612823666171010124414
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The incidence and prevalence of inflammatory bowel diseases (IBD), which comprise ulcerative colitis and Crohn's disease, are increasing dramatically worldwide. Immunomodulators and biological agents can help but cause severe side effects in long-term use. As such, complementary and alternative medicine, in particular herbal remedy, is becoming more and more popular in the treatment of IBD patients. Many natural compounds have been used in clinical trials and some have been proven promising in IBD treatment. To achieve a better understanding of herbal therapy, researchers focus on understanding the underlying mechanisms by using experimental rodent models. The mechanism of the pathogenesis of IBD is complex involving both environmental and genetic factors. IBD is considered as a consequence of impaired epithelial barrier function, gut microbiota dysbiosis, and aberrant immune response. Studies have demonstrated that herbal medicine can improve epithelial proliferation and barrier integrity, restore microbiota homeostasis, and suppress hyper-immune reaction. This review is to summarize current understanding of the molecular basis of herbal treatment of IBD at the levels of epithelial, microbial, and immune regulation.
引用
收藏
页码:5173 / 5179
页数:7
相关论文
共 94 条
[1]   Interactions Between the Host Innate Immune System and Microbes in Inflammatory Bowel Disease [J].
Abraham, Clara ;
Medzhitov, Ruslan .
GASTROENTEROLOGY, 2011, 140 (06) :1729-1737
[2]   Epidemiology and risk factors for IBD [J].
Ananthakrishnan, Ashwin N. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (04) :205-217
[3]  
Molodecky Natalie A, 2010, Gastroenterol Hepatol (N Y), V6, P339
[4]   Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice [J].
Araki, Yoshio ;
Mukaisyo, Ken-Ichi ;
Sugihara, Hiroyuki ;
Fujiyama, Yoshihide ;
Hattori, Takanori .
ONCOLOGY REPORTS, 2010, 24 (04) :869-874
[5]   NF-κB in inflammatory bowel disease [J].
Atreya, I. ;
Atreya, R. ;
Neurath, M. F. .
JOURNAL OF INTERNAL MEDICINE, 2008, 263 (06) :591-596
[6]   The intestinal stem cell [J].
Barker, Nick ;
van de Wetering, Marc ;
Clevers, Hans .
GENES & DEVELOPMENT, 2008, 22 (14) :1856-1864
[7]  
Basch Ethan, 2004, Journal of Herbal Pharmacotherapy, V4, P63, DOI [10.1080/J157v04n03_06, 10.1080/J157v04n02_07]
[8]   Intestinal permeability - a new target for disease prevention and therapy [J].
Bischoff, Stephan C. ;
Barbara, Giovanni ;
Buurman, Wim ;
Ockhuizen, Theo ;
Schulzke, Joerg-Dieter ;
Serino, Matteo ;
Tilg, Herbert ;
Watson, Alastair ;
Wells, Jerry M. .
BMC GASTROENTEROLOGY, 2014, 14
[9]   Regulatory T cells in inflammatory bowel disease [J].
Boden, Elisa K. ;
Snapper, Scott B. .
CURRENT OPINION IN GASTROENTEROLOGY, 2008, 24 (06) :733-741
[10]   Cytokine regulation of tight junctions [J].
Capaldo, Christopher T. ;
Nusrat, Asma .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (04) :864-871